(Reuters) – Medical device maker Boston Scientific beat analysts’ estimates for second-quarter profit on Wednesday, helped by strong demand for its heart devices.
On an adjusted basis, Boston Scientific earned 62 cents per share in the second quarter, compared with estimates of 58 cents, according to LSEG data.
(Reporting by Puyaan Singh and Mariam Sunny in Bengaluru; Editing by Shounak Dasgupta)
Comments